ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2025: USD 638.18 M

ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 638.18 M for the Trailing 12 Months (TTM) ending June 30, 2025, a 2.86% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 620.43 M, a 3.43% change year over year.
  • ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 599.85 M, a 28.11% change year over year.
  • ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 468.23 M, a 61.06% change year over year.
  • ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 290.72 M, a 5.31% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue